Biomerica, Inc. (NASDAQ:BMRA) Short Interest Up 50.5% in October

Biomerica, Inc. (NASDAQ:BMRA) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 562,400 shares, a growth of 50.5% from the October 15th total of 373,700 shares. Based on an average daily volume of 446,300 shares, the short-interest ratio is presently 1.3 days.

Institutional Investors Weigh In On Biomerica

An institutional investor recently bought a new position in Biomerica stock. Perritt Capital Management Inc bought a new stake in Biomerica, Inc. (NASDAQ:BMRA) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 70,000 shares of the company’s stock, valued at approximately $31,000. Perritt Capital Management Inc owned about 0.42% of Biomerica at the end of the most recent quarter. 22.28% of the stock is owned by institutional investors and hedge funds.

Biomerica Stock Performance

Shares of BMRA stock opened at $0.36 on Thursday. Biomerica has a fifty-two week low of $0.24 and a fifty-two week high of $2.13. The business has a fifty day simple moving average of $0.33 and a 200-day simple moving average of $0.42.

Biomerica (NASDAQ:BMRA) last posted its earnings results on Tuesday, October 15th. The company reported ($0.08) earnings per share for the quarter. Biomerica had a negative net margin of 111.89% and a negative return on equity of 84.62%. The business had revenue of $1.81 million for the quarter.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.